{"retracted":false,"update":{"timestamp":1468195200000,"doi":"10.1007/s40267-016-0327-0","type":"correction"},"doi":"10.1007/s40267-016-0311-8","journal":"Drugs & Therapy Perspectives","publisher":"Springer Nature","title":"Erratum to: Vedolizumab in moderately to severely active ulcerative colitis or Crohnâ€™s disease: a guide to its use"}
